Monosodium Glutamate on Gastric Emptying

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children with a radionuclide gastric emptying test with abnormal results will undergo a second test with the addition of a weight adjusted dose of monosodium glutamate. The purpose of the study is to determine if a single dose of monosodium glutamate can shorten the gastric emptying time.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Monosodium Glutamate Supplementation on Gastric Emptying and Postprandial Nitrogen Kinetics

NCT00862017

Healthy

COMPLETED NA

Ghrelin and Gastric Emptying in Children With Functional Dyspepsia

NCT01591174

Functional Dyspepsia

COMPLETED

Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

NCT00008736

Infant, Newborn, Diseases

COMPLETED PHASE2

Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

NCT03105362

Short Bowel Syndrome

TERMINATED NA

Domperidone in Refractory Gastroparesis

NCT00760461

Gastroparesis

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is evidence that monosodium glutamate has effects on synapsis at the gastric and duodenum level that results in stimulation of contractility resulting on increase rate of gastric emptying. The purpose of the study is to demonstrate that the administration of a single dose of monosodium glutamate can shorten the gastric emptying time.

Patients with a prior study indicating a delay of gastric empting time, will undergo a second test with the addition of a weight adjusted dose of monosodium glutamate. Each patient will serve as her/his own control. Results will be analysed by pair-T test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delayed Gastric Emptying

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With monosodium glutamate

Results of one time gastric emptying study with a single dose of monosodium glutamate; 1 g for weight greater than 45 kg, 700mg between 35 and 44,900 kg, 600mg between 25 and 34,900, 500mg between 15 and 25 kg and 250mg in less than 15 kg

Group Type OTHER

Monosodium glutamate

Intervention Type DIETARY_SUPPLEMENT

A single dose of weight adjusted monosodium glutamate will be added at the time of a repeat radionuclide gastric emptying study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.